SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Marathon Petroleum Corp. engages in the refining, marketing, and transportation of petroleum products. It operates through the Refining and Marketing, and Midstream segments. The Refining and Marketing segment includes refining crude oil and other feedstocks, purchasing ethanol, and refined products for resale and distribution of refined products. The Midstream segment refers to transportation, storing, distribution, and marketing of crude oil and refined products. The company was founded in 1887 and is headquartered in Findlay, OH.

Marathon Petroleum Corp

Elevated refining margins and fuel-supply disruptions linked to Middle East and Russian refinery constraints are driving MPCs rally and repeated record highs, alongside broader strength in U.S. refiners. Traders are largely bullish on sustained profitability, though some warn the move is overextended and that falling crack spreads or easing geopolitical disruptions could pressure margins.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is drawing attention after a rebound, with traders highlighting the new CEO, the v5.0 mainnet upgrade, and live post-quantum account features as potential catalysts for renewed adoption and institutional use. Bulls are accumulating and expecting an altcoin-driven recovery, while skeptics cite weak price performance, dilution, and limited revenue as reasons the move may not hold.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

A sharp Bitcoin rebound, supported by short covering and renewed crypto demand, is driving attention to IBIT. Traders are split between viewing the move as a bullish breakout despite the failed CLARITY Act and warning that higher rates, resistance, and hawkish macro conditions could trigger a pullback.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The stalled Senate Clarity Act and subsequent SEC/CFTC efforts to establish crypto-market rules are driving XRP discussion, with traders debating whether agency-led regulation can offset the loss of durable legislation. Bulls view the regulatory developments and XRPs established legal position as supportive, while skeptics argue the setback removes a key catalyst and leaves the token reliant on speculative hype.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

Optimism around XRP exchange-traded fund demand, institutional adoption, and potential U.S. regulatory clarity under the CLARITY Act is driving attention, with traders debating whether these catalysts can support further gains. Bullish posts highlight ETF inflows and payment-network developments, while skeptics cite weak volume, dependence on Bitcoin, and the possibility that regulatory optimism is already priced in.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

A stock-and-warrant offering and broader dilution concerns have pressured Centrus Energy, prompting debate over near-term shareholder dilution, expansion costs, and weak price action. Bulls argue the capital supports domestic LEU/HALEU capacity and long-term nuclear-fuel demand, while skeptics remain concerned about valuation and execution.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Middle East tensions and Strait of Hormuz supply-disruption concerns are keeping crude prices and Chevron in focus, with traders viewing the company as a beneficiary of higher oil prices. The community is also debating Chevrons planned Venezuelan expansion, balancing potential long-term production growth against political risk and the possibility that de-escalation or additional supply could unwind the oil premium.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

A broader crypto rebound and speculation about short liquidations are driving attention to PEPE, with traders repeatedly framing the move as a potential breakout or short squeeze and discussing accumulation around the consolidation range. The community remains divided, with bullish holders expecting further meme-coin momentum while skeptics point to low volume, manipulation concerns, and the risk of another pullback.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Record-high diesel and refining crack spreads, driven by constrained global fuel supply and refinery disruptions, are fueling attention on Valero and other refiners. Traders remain bullish on margin strength and repeated all-time highs, while bears argue the rally is overbought and vulnerable to falling spreads, profit-taking, or easing geopolitical disruptions.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumens AI-network transformation is driving attention, centered on its Alkira integration, Network-as-a-Service growth and private-fiber opportunities, with speculation that Nvidia or other hyperscaler deals could expand the opportunity. Traders remain divided: bulls see an undervalued AI-infrastructure turnaround, while skeptics point to continued legacy-business declines, debt, limited near-term revenue visibility and the lack of a buyback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMRN In Spain, the High Court of Justice has upheld the decision of Osakidetza (the Basque public Healthcare Service) to deny funding for a medication costing roughly 840,000 euros per year. The case involves a patient diagnosed with generalized acquired lipodystrophy, a rare condition that causes progressive fat loss and dangerous metabolic complications. 
 
Her endocrinologist requested metreleptina (marketed as Myalepta), an orphan drug not officially marketed or publicly funded in Spain for this use. 
 
Experts argued that the drug&#39;s clinical efficacy is uncertain and that other funded treatments like VAZKEPA could achieve superior reductions in triglycerides. 
 
https://gananzia.com/la-justicia-avala-que-osakidetza-niegue-a-una-paciente-un-tratamiento-de-840-000-euros-anuales-porque-su-eficacia-clinica-es-discutida/

Fritschya1

sanam

Jeff

Moi Aussi

Ron Veres

GreenTurtle

1of789

Wikthor

Good Times

Mark Roth

El Tribunal Superior de Justicia del País Vasco (TSJPV) ha avalado la decisión de Osakidetza de no financiar a una paciente guipuzcoana un medicamento cuyo coste asciende a unos 840.000 euros al añ...

Gananzia

La Justicia avala que Osakidetza niegue a una paciente un tratamiento de 840.000 euros anuales porque su eficacia clínica es discutida

StockTwits Web

Amarin Corp - ADR

 In Spain, the High Court of Justice has upheld the decision of Osakidetza (the Basque public Healthcare Service) to deny funding for a medication costing roughly 840,000 euros per year. The case involves a patient diagnosed with generalized acquired lipodystrophy, a rare condition that causes progressive fat loss and dangerous metabolic complications. 
 
Her endocrinologist requested metreleptina (marketed as Myalepta), an orphan drug not officially marketed or publicly funded in Spain for this use. 
 
Experts argued that the drug's clinical efficacy is uncertain and that other funded treatments like VAZKEPA could achieve superior reductions in triglycerides. 
 


Enrique Viladomiu

@EnVila Osakidetza experts also pointed out the existence of treatments that could achieve greater reductions. Among them, they cited Vazkepa combined with statins, with reductions of up to 41%; volanesorsen, up to 77%; and olezarsen, between 40% and 60%. During the trial, the patient&#39;s endocrinologist admitted that she was unfamiliar with some of these newer medications and stated that she had exhausted &quot;the therapeutic arsenal that I know of.&quot;

 Osakidetza experts also pointed out the existence of treatments that could achieve greater reductions. Among them, they cited Vazkepa combined with statins, with reductions of up to 41%; volanesorsen, up to 77%; and olezarsen, between 40% and 60%. During the trial, the patient's endocrinologist admitted that she was unfamiliar with some of these newer medications and stated that she had exhausted "the therapeutic arsenal that I know of."